Epikast raised $2.2M Series B venture round, led by Kos Biotechnology Partners.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$2.2M
Top Valuation
-
Epikast raised $2.2M in a Series B round.
The round was announced on 01/30/26.
The round was led by Kos Biotechnology Partners.